| Literature DB >> 30070994 |
Anne-Catrin Adam1, Kaja Helvik Skjærven1, Paul Whatmore1, Mari Moren1, Kai Kristoffer Lie1.
Abstract
Disproportionate high intake of n-6 polyunsaturated fatty acids (PUFAs) in the diet is considered as a major human health concern. The present study examines changes in the hepatic gene expression pattern of adult male zebrafish progeny associated with high levels of the n-6 PUFA arachidonic acid (ARA) in the parental diet. The parental generation (F0) was fed a diet which was either low (control) or high in ARA (high ARA). Progenies of both groups (F1) were given the control diet. No differences in body weight were found between the diet groups within adult stages of either F0 or F1 generation. Few differentially expressed genes were observed between the two dietary groups in the F0 in contrast to the F1 generation. Several links were found between the previous metabolic analysis of the parental fish and the gene expression analysis in their adult progeny. Main gene expression differences in the progeny were observed related to lipid and retinoid metabolism by PPARα/RXRα playing a central role in mediating changes to lipid and long-chain fatty acid metabolism. The enrichment of genes involved in β-oxidation observed in the progeny, corresponded to the increase in peroxisomal β-oxidative degradation of long-chain fatty acids in the parental fish metabolomics data. Similar links between the F0 and F1 generation were identified for the methionine cycle and transsulfuration pathway in the high ARA group. In addition, estrogen signalling was found to be affected by parental high dietary ARA levels, where gene expression was opposite directed in F1 compared to F0. This study shows that the dietary n-3/n-6 PUFA ratio can alter gene expression patterns in the adult progeny. Whether the effect is mediated by permanent epigenetic mechanisms regulating gene expression in developing gametes needs to be further investigated.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30070994 PMCID: PMC6071982 DOI: 10.1371/journal.pone.0201278
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Experimental design of the transgenerational zebrafish feeding trial.
F0 zebrafish from both control and high ARA group were fed a start feed containing Gemma micro® and Artemia nauplii from 5 DPF until 26 DPF. The two experimental groups were given either a control or high ARA diet from 27 DPF onwards until sampling. F0 fish were mated at 97 DPF to produce F1 generation. Both groups in the F1 generation were fed the control diet from 27 DPF until sampling. F0 and F1 body weight (grams) and liver tissue sampling for transcriptome analysis (RNA-sequencing) were performed at 154–156 DPF (F0) and 140–142 DPF (F1).
Body weight of F0 zebrafish and their progeny (F1).
| Control (g) | High ARA (g) | ||||||
|---|---|---|---|---|---|---|---|
| Mean | SD | n 1 | Mean | SD | n | p | |
| F0 fish (154–156 DPF) | 0.44 | 0.05 | 36 | 0.42 | 0.06 | 36 | 0.19 |
| F1 fish (140–142 DPF) | 0.35 | 0.04 | 36 | 0.34 | 0.06 | 35 | 0.40 |
Fish age is given in days post fertilization (DPF).
1 n are individual fish originated from six tanks.
2 An unpaired, two-tailed t-test (GraphPad) was used for significance testing (p<0.05).
Fig 2Principal component analysis of RNA-sequencing data from male livers in F0 generation fed either a control or high ARA diet and their F1 progeny fed the control diet.
The plot displays high similarity in the transcriptome of F0 control and high ARA livers compared to clearer separation in gene expression patterns between the F1 diet groups. The magnitude of variation between replicates within a diet group were similar among all groups. Plot shows data underlying log-transformed read counts based on RefSeq reference genome mapping.
Fig 3Volcano plot of RNA-sequencing data from male livers in F0 generation fed either a control or high ARA diet and their F1 progeny where both groups received the control diet.
Presented data represents overlapping genes from both RefSeq and Ensembl reference genome mapping (GRCz10). Red spots represent differentially expressed genes (DEGs) between control and high ARA group in F0 (A) and F1 (B) generation. The green line denoted the significance threshold (adjusted p<0.05) for DEGs.
Significant canonical pathways associated with DEGs from F1 high ARA livers proposed by IPA®.
| Canonical Pathways | p-value | z-score | Gene symbols |
|---|---|---|---|
| 3.98E-13 | -2.887 | RPL32,RPL11,RPL36A,RPS27,RPS8,RPS18,RPL29,EIF4G3,EIF2S1,XIAP,RPS28,RPS7,RPS26,SREBF1,RPL19,RPL21,RPL5,RPS25,RPS15A,RPS2,RPL36,RPS17,RPL18,RPL38 | |
| 5.13E-03 | -2.000 | APOB,C3,SREBF1,FASN,ACACA,SERPINA1,RXRA | |
| 4.47E-02 | -1.342 | PLCD3,PLCE1,PRKCQ,PRKAG2,GRM6 | |
| 3.80E-02 | -1.000 | PLCD3,PLCE1,PRKCQ,PRKAG2 | |
| 3.31E-03 | 0.447 | PLCD3,PLCE1,GPD1,HELZ2,ACOX1,FASN,PRKAG2,RXRA,ADIPOR1 | |
| 3.89E-04 | 0.447 | ALDH1L1,SCARB1,CYP3A4,SREBF1,ACOX1,SULT1A1,ALDH1A2,SULT1A3/SULT1A4,FABP7,GSTA1,RXRA,FMO5 | |
| 2.82E-02 | -0.447 | PLCD3,PLCE1,PRKCQ,CACNA1H,PRKAG2,PDE4B | |
| 2.63E-06 | ITGB1,RPS27,RPS8,RPS18,EIF4G3,EIF2S1,RPS28,RPS7,RPS26,RPS25,RPS15A,RPS2,RPS17 | ||
| 7.76E-06 | RPS28,RPS7,DGKZ,PRKCQ,RPS26,RPS27,RPS18,RPS8,PRKAG2,EIF4G3,RPS25,RPS15A,RPS2,RPS17 | ||
| 3.02E-05 | AZIN1,SAT2,PSME4,OAZ1,OAZ2 | ||
| 2.45E-04 | HSPA4,SREBF1,EDEM1,HSPA9,VCP,CANX | ||
| 1.20E-03 | ALDH1L1,COMT,SULT1A1,ALDH1A2,SULT1A3/SULT1A4 | ||
| 1.78E-03 | CBS/CBSL,MAT1A,CTH,PRMT1 | ||
| 1.91E-03 | APOB,C3,SCARB1,SREBF1,FASN,SERPINA1,RXRA,VLDLR | ||
| 2.82E-03 | ALDH1L1,TFDP1,ALDH1A2,GSTA1,RXRA,ESR1,PTGES3,AHR | ||
| 3.80E-03 | B2M,HSPA4,UBE2D2,UBE4B,UBE2H,DNAJB11,DNAJC19,HSPA9,HSPD1,THOP1,XIAP | ||
| 4.47E-03 | CBS/CBSL,MAT1A,GOT1,CTH,PRMT1 | ||
| 5.37E-03 | CYP46A1,UROC1,MICAL2 | ||
| 6.92E-03 | ITGB1,B2M,COPG2,COPB2,COPB1 | ||
| 7.08E-03 | CBS/CBSL,CTH | ||
| 8.51E-03 | LOC102724788/PRODH,OAT,GLS2 | ||
| 8.51E-03 | ALDH1L1,PRKCQ,CYP3A4,SULT1A1,ALDH1A2,SULT1A3/SULT1A4,GSTA1,RXRA,FMO5,PTGES3,AHR | ||
| 8.71E-03 | PLCD3,HSPA4,PLCE1,PRKCQ,DNAJB11,DNAJC19,HSPA9,HSPD1 | ||
| 1.12E-02 | LARS,CARS,TARS,VARS,QARS | ||
| 1.78E-02 | PLCD3,PLCE1,PRKCQ,PRKAG2,TAS1R3 | ||
| 1.95E-02 | ALDH1L1,ALDH1A2,SAT2 | ||
| 2.40E-02 | LOC102724788/PRODH,OAT,GLS2 | ||
| 2.45E-02 | PTGDS,PTGES3 | ||
| 2.75E-02 | CYP3A4,PRKAG2,GSTA1,RXRA | ||
| 2.95E-02 | SCARB1,SREBF1,FASN,ACACA,RXRA | ||
| 3.09E-02 | CYP46A1,MICAL2 | ||
| 3.89E-02 | PRKAG2,THOP1,ACE | ||
| 4.07E-02 | SERPINB1,YY1,PRKCQ,RXRA | ||
| 4.37E-02 | PRKCQ,ALDH1A2,PRKAG2,RBP2,SMARCD1,RXRA,PRMT1 | ||
| 4.57E-02 | EIF2S1,TAOK3 | ||
| 5.01E-02 | RGN,PGM2 | ||
| 5.01E-02 | PGLS,RPIA | ||
| 5.01E-02 | ITGB1,MRC1,PLCD3,PLCE1,PRKCQ |
1 IPA® predicts upregulation (positive z-score) or downregulation (negative z-score) of canonical pathways.
2 Gene symbols are reported as human orthologue gene symbols.
The top most significantly enriched lipid metabolism related biological functions associated with DEGs from F1 high ARA livers proposed by IPA®.
| Biological Functions | p-value | z-score | Gene symbols |
|---|---|---|---|
| 3.82E-04 | 1.969 | ACACA,CBS/CBSL,CHKA,DGKZ,FASN,LYST,NPC2,PITPNB,PLPP2,RGN,SCARB1,SREBF1,VLDLR | |
| 5.72E-03 | -1.960 | C3,CYP3A4,SCARB1,VLDLR | |
| 2.04E-03 | 1.622 | ACACA,ACOX1,ADIPOR1,C3,CYP3A4,FASN,PDK4,PRKAG2,SLC25A17,SLCO2A1,SREBF1 | |
| 3.27E-06 | -1.375 | ACACA,ACLY,AHR,AKR1B1,ALDH1A2,APOB,ATP1A1,BCO1,C3,CACNA1H,CD9,CERS5,CHKA,CREB3L3,CYP39A1,CYP3A4,CYP46A1,DAGLA,DGKZ,ELOVL4,ESR1,FASN,FDX1,GSTA1,IGFBP2,ITGB1,LEPR,NPC2,PARK7,PDK4,PLCE1,PRKAG2,PTGDS,PTGES3,RGN,RXRA,SCARB1,SERPINA1,SH3KBP1,SREBF1 | |
| 6.15E-03 | 1.342 | ACACA,CHKA,FASN,LYST,SREBF1 | |
| 4.49E-03 | 1.257 | ABCC6,FABP7,SCARB1,SLC13A3,SLC25A17,SLCO2A1 | |
| 2.26E-06 | 1.145 | ACACA,ACLY,ADIPOR1,AKR1B1,APOB,ATP2A2,C3,CBS/CBSL,CHKA,CREB3L3,CYP3A4,DAGLA,FASN,FMO5,HELZ2,LEPR,MGLL,PDK4,RGN,RXRA,SCARB1,SREBF1,STEAP4,VLDLR | |
| 4.41E-04 | -1.131 | ACLY,AHR,ALDH1A2,APOB,ATP1A1,BCO1,CACNA1H,CYP39A1,CYP46A1,ESR1,FDX1,GSTA1,IGFBP2,PRKAG2,SCARB1,SERPINA1,SREBF1 | |
| 6.20E-03 | -1.127 | ACLY,C3,FASN,SCARB1 | |
| 5.80E-03 | -1.067 | CBS/CBSL,COMT,ESR1,LEPR,SCARB1 |
1 IPA® predicts upregulation (positive z-score) or downregulation (negative z-score) of canonical pathways.
2 Gene symbols are reported as human orthologue gene symbols.
Fig 4Differential expression of genes involved in retinoid processing and putative interactions with the PPARα/RXRα pathway and lipid signalling in male livers that are associated with parental high dietary ARA levels.
Filled shapes in the figure represent overlapping differentially expressed genes between RefSeq and Ensembl annotation. Shapes that are highlighted with glow underlie gene expression information exclusively from Ensembl annotation (S4 Table); acaca (acetyl-CoA carboxylase alpha), aclya (ATP citrate lyase a); acox1 (acyl-CoA oxidase 1, palmitoyl; alias: peroxisomal acyl-CoA oxidase 1); aldh1a2 (aldehyde dehydrogenase 1 family, member A2); bco1 (beta-carotene oxygenase 1); crabp2b (cellular retinoic acid binding protein 2, b); dagla (diacylglycerol lipase, alpha); dgkza (diacylglycerol kinase, zeta a), elovl4b (ELOVL fatty acid elongase 4b); fabp7a (fatty acid binding protein 7, brain, a); fasn (fatty acid synthase); helz2 (helicase with zinc finger 2, transcriptional coactivator); lrata (lecithin retinol acyltransferase a (phosphatidylcholine-retinol O-acyltransferase)); lratb (lecithin retinol acyltransferase b (phosphatidylcholine-retinol O-acyltransferase)); pparaa (peroxisome proliferator-activated receptor alpha a); prkcq (protein kinase C, theta); rbp2b (retinol binding protein 2b, cellular); rdh1 (retinol dehydrogenase 1); retsat (retinol saturase (all-trans-retinol 13,14-reductase)); rxraa (retinoid X receptor, alpha a); scarb1 (scavenger receptor class B, member 1); srebf1 (sterol regulatory element binding transcription factor 1); vldlr (very low density lipoprotein receptor).
Fig 5Parental high ARA levels are associated with differential expression of genes involved in methionine cycle, transsulfuration pathway, and glutamate and glutathione metabolism in male F1 livers.
Filled shapes in the figure represent overlapping differentially expressed genes between RefSeq and Ensembl annotation. Shapes that are highlighted with glow underlie gene expression information exclusively from Ensembl annotation (S4 Table); ahcy (adenosylhomocysteinase); aldh1l1 (aldehyde dehydrogenase 1 family, member L1); cbsb (cystathionine-beta-synthase b); cth (cystathionase (cystathionine gamma-lyase)); gart (phosphoribosylglycinamide formyltransferase); gclc (glutamate-cysteine ligase, catalytic subunit); gls2b (glutaminase 2b (liver, mitochondrial); glud1a (glutamate dehydrogenase 1a); got1 (glutamic-oxaloacetic transaminase 1); gpx1b (glutathione peroxidase 1b); GSH (reduced glutathione); gsr (glutathione-disulfide reductase); gss (glutathione synthetase); GSSG (oxidized glutathione); gsta.1 (glutathione S-transferase, alpha tandem duplicate 1); mat1a (methionine adenosyltransferase I alpha); msra (methionine sulfoxide reductase A); mthfr (methylenetetrahydrofolate reductase (NAD(P)H)); mtr (5-methyltetrahydrofolate-homocysteine methyltransferase); oplah (5-oxoprolinase (ATP-hydrolysing)); prmt1 (protein arginine methyltransferase 1); R-S-glutathione (glutathione-S-conjugate); SAH (S-adenosyl-homocysteine); SAM (S-adenosyl-methionine); γ-Glu-Cys (gamma-glutamyl-cysteine); THF (tetrahydrofolate); 5-methyl-THF (5-methyltetrahydrofolate); 10-COH-THF (10-formyl-tetrahydrofolate); 5,10-meTHF (5,10-methylene-THF).